• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Osteofibrous Dysplasia

Article

A 13-year-old boy presents with increasing right calf mass.

History: A 13-year-old boy presents with increasing right calf mass. 

Sagittal proton density image of the area of concern:

Axial fat suppressed images through the area of concern:

 

 

Diagnosis: Osteofibrous dysplasia

Findings: Cortically based lucency of the middle tibia. No medullary involvement and without periosteal reaction. Status post bone graft packing on final images. 

Comments: Osteofibrous dysplasia is a rare bone tumor of the tubular bones, most commonly in the anterior cortex of the tibia, which is often referred to as an ossifying fibroma of the tubular bones. Thought to exist within a spectrum of benign to malignant with adamantinoma. Treatment is controversial but follow up radiographs and careful observation is paramount to assess for possible degeneration to adamantinoma.

Resources:

Resnick, Kransdorf, Bone and Joint Imaging 3rd Edition. 2005.
“Osteofibrous dysplasia of the tibia. Is there a need for a radical surgical approach?” Lee RS, Weitzel S, Eastwood DM, Monsell F, Pringle J, Cannon SR, Briggs TW.
“Adamantinoma of tibia: a study of 12 cases” Desai SS, Jambhekar N, Agarwal M, Puri A, Merchant N.
EMedicine.com: Osteofibrous Dysplasia

Case courtesy Hospital for Special Surgery. Click here for more Case Studies from HSS. 

Recent Videos
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
Multimodal AI with CCTA and MRI Data Shows Promise in Predicting MACE in Patients with Obstructive CAD

Multimodal AI with CCTA and MRI Data Shows Promise in Predicting MACE in Patients with Obstructive CAD

Jeff Hall
January 29th 2025
Article

For patients with newly diagnosed obstructive coronary artery disease (CAD), a multimodal machine learning model offered an 86 percent AUC for predicting MACE, which was 10 percent higher than CCTA alone and over 35 percent higher than the Framingham Risk Score.

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

Jeff Hall
September 1st 2023
Podcast

In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.

FDA Clears AI-Enhanced Portfolio of Ultrasound Systems for Women with High-Risk Pregnancies

FDA Clears AI-Enhanced Portfolio of Ultrasound Systems for Women with High-Risk Pregnancies

Jeff Hall
January 28th 2025
Article

An array of AI-powered features and automated tools may lead to improved workflow and image quality with the Voluson Expert 22, 20 and 18 ultrasound systems.

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 2

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 2

Jeff Hall
August 23rd 2023
Podcast

In the second episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss recent studies published by the Journal of the American Medical Association (JAMA) that suggested moving to more of a risk-adapted model for mammography screening.

Emerging PET Agent Garners Second FDA Fast Track Designation for Prostate Cancer Imaging

Emerging PET Agent Garners Second FDA Fast Track Designation for Prostate Cancer Imaging

Jeff Hall
January 24th 2025
Article

In addition to an August FDA fast track designation for PSMA PET imaging in patients with suspected metastasis, the radiopharmaceutical 64Cu-SAR-bisPSMA has earned another fast track designation for imaging of biochemical recurrence.

Study Examines Prognostic Value of Baseline PSMA PET/CT Factors in Patients with mCRPC

Study Examines Prognostic Value of Baseline PSMA PET/CT Factors in Patients with mCRPC

Jeff Hall
January 24th 2025
Article

Doubling of total tumor volume on PSMA PET/CT is 41 percent more likely to reduce overall survival in patients with metastatic castration-resistant prostate cancer (mCRPC), according to new research.

© 2025 MJH Life Sciences

All rights reserved.